{"id":19330,"date":"2016-02-23T13:31:28","date_gmt":"2016-02-23T12:31:28","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=19330"},"modified":"2016-02-23T13:31:28","modified_gmt":"2016-02-23T12:31:28","slug":"taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/","title":{"rendered":"Taller de comparacions indirectes i metan\u00e0lisi en xarxa"},"content":{"rendered":"<figure id=\"attachment_19386\" aria-describedby=\"caption-attachment-19386\" style=\"width: 367px\" class=\"wp-caption alignright\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/02\/comparacions-indirectes-metaanalisi-xarxa-4.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\" wp-image-19386\" alt=\"comparacions-indirectes-metaanalisi-xarxa (4)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/02\/comparacions-indirectes-metaanalisi-xarxa-4.jpg\" width=\"367\" height=\"210\" \/><\/a><figcaption id=\"caption-attachment-19386\" class=\"wp-caption-text\">Aurelio Tob\u00edas, docent del curs, durant la seva intervenci\u00f3<\/figcaption><\/figure>\n<p>\u201cCada any es comercialitzen nous principis actius i nous medicaments per indicacions on ja tenim diferents tractaments establerts. Les ag\u00e8ncies reguladores, tant a nivell americ\u00e0 com a nivell europeu, nom\u00e9s requereixen a la ind\u00fastria farmac\u00e8utica que el nou medicament hagi demostrat efic\u00e0cia i seguretat enfront placebo per donar l\u2019autoritzaci\u00f3 a la seva comercialitzaci\u00f3. No cal que el nou medicament, per estar disponible en el mercat, hagi demostrat no inferioritat o superioritat en comparaci\u00f3 als tractaments ja comercialitzats amb la seva mateixa indicaci\u00f3 o per la mateixa patologia\u201d explica <strong>Roser Vall\u00e8s, vocal d\u2019Atenci\u00f3 Prim\u00e0ria del COFB<\/strong>: &#8220;Aix\u00f2 implica que <b>el professional sanitari<\/b>, quan ha de valorar si el nou medicament li aporta alguna avantatge enfront als tractaments ja coneguts o quan vol establir el lloc en terap\u00e8utica d\u2019aquesta novetat, <b>moltes vegades no disposa d\u2019estudis comparatius directes (assaigs cl\u00ednics, metan\u00e0lisi) que li permetin establir correctament quines avantatges o desavantatges li pot aportar aquest nou medicament&#8221;.<\/b><\/p>\n<figure id=\"attachment_19385\" aria-describedby=\"caption-attachment-19385\" style=\"width: 306px\" class=\"wp-caption alignleft\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/02\/comparacions-indirectes-metaanalisi-xarxa-3.jpg\"><img decoding=\"async\" class=\" wp-image-19385 \" alt=\"comparacions-indirectes-metaanalisi-xarxa (3)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/02\/comparacions-indirectes-metaanalisi-xarxa-3.jpg\" width=\"306\" height=\"204\" \/><\/a><figcaption id=\"caption-attachment-19385\" class=\"wp-caption-text\">Roser Vall\u00e8s, vocal d\u2019Atenci\u00f3 Prim\u00e0ria del COFB, i una de les coordinadores de la formaci\u00f3<\/figcaption><\/figure>\n<p>\u201cPer intentar pal\u00b7liar aquesta manca d\u2019evid\u00e8ncia cient\u00edfica en els darrers anys s\u2019estan publicant molts estudis de metan\u00e0lisi indirectes i m\u00e9s recentment els metan\u00e0lisi en xarxa per intentar establir comparacions entre diferents f\u00e0rmacs que no disposen de comparacions directes entre s\u00ed\u201d matisa Vall\u00e8s. El <b>Taller de comparacions indirectes i metan\u00e0lisi en xarxa,<\/b> que va acollir el COFB el passat 4 de febrer, va permetre als assistents introduir aquests conceptes i tamb\u00e9 els principals models de consist\u00e8ncia i inconsist\u00e8ncia per a l\u2019an\u00e0lisi estad\u00edstica d\u2019una metan\u00e0lisi en xarxa. La formaci\u00f3 va anar a c\u00e0rrec d\u2019<b>Aurelio Tob\u00edas<\/b>, doctor en medicina preventiva i salut p\u00fablica, llicenciat en ci\u00e8ncies i t\u00e8cnica estad\u00edstica i diplomat en estad\u00edstica, investigador cient\u00edfic del Consejo Superior de Investigaciones Cient\u00edficas (CSIC) a l\u2019Instituto de Diagn\u00f2stico Ambiental y Estudios del Agua en Barcelona, i investigador visitant en la London School of Hygiene and Tropical Medicine a Londres.<\/p>\n<p>\u201cEls conceptes b\u00e0sics de com es fan aquestes comparacions i metan\u00e0lisi s\u00f3n molt \u00fatils per als farmac\u00e8utics cl\u00ednics perqu\u00e8<b> ens ajuden a saber interpretar millor els resultats d\u2019aquests estudis i establir la seva rellev\u00e0ncia dins l\u2019an\u00e0lisi global que fem del lloc en terap\u00e8utica de les novetats terap\u00e8utiques que constantment estan apareixent en el mercat en les condicions anteriorment descrites<\/b>\u201d explica Vall\u00e8s, una de les coordinadores de la formaci\u00f3, juntament amb Esther Amado, vocal a Catalunya de la Sociedad Espa\u00f1ola de Farmac\u00e9uticos de Atenci\u00f3n Primaria (SEFAP), Tom\u00e0s Casas\u00edn, vocal d\u2019Hospitals del COFB, i Julio Mart\u00ednez, president de la Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC).<\/p>\n<div class=\"box shadow\">En el context d\u2019una revisi\u00f3 sistem\u00e0tica, una metan\u00e0lisi en xarxa \u00e9s una extensi\u00f3 de la metan\u00e0lisi cl\u00e0ssica de comparacions directes en qu\u00e8 en lloc de fer una metan\u00e0lisi per separat de diversos estudis per al tractament A amb relaci\u00f3 al comparador B (A comparat amb B) o per al tractament C respecte del comparador B (C comparat amb B), es fa una valoraci\u00f3 de la xarxa completa combinant les comparacions directes i indirectes entre diversos tractaments que competeixen entre s\u00ed en la pr\u00e0ctica cl\u00ednica (A comparat amb B, C comparat amb B i B comparat amb A).<\/div>\n<p><span style=\"color: #888888;\"><b>Activitat organitzada conjuntament amb la Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC) i la Sociedad Espa\u00f1ola de Farmac\u00e9uticos de Atenci\u00f3n Primaria (SEFAP).<\/b><b>\u00a0<\/b><\/span><\/p>\n<p align=\"right\"><b>Amb la col\u00b7laboraci\u00f3 de:<\/b><\/p>\n<p align=\"right\"><b><a href=\"http:\/\/www.astellas.es\/\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" class=\"alignright size-thumbnail wp-image-19331\" alt=\"astellas-logo\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/02\/astellas-logo-150x62.jpg\" width=\"150\" height=\"62\" \/><\/a> <\/b><\/p>\n<p align=\"right\">\n","protected":false},"excerpt":{"rendered":"<p>\u201cCada any es comercialitzen nous principis actius i nous medicaments per indicacions on ja tenim diferents tractaments establerts. Les ag\u00e8ncies reguladores, tant a nivell americ\u00e0 com a nivell europeu, nom\u00e9s requereixen a la ind\u00fastria farmac\u00e8utica que el nou medicament hagi demostrat efic\u00e0cia i seguretat enfront placebo per donar l\u2019autoritzaci\u00f3 a [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":19386,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[938,2322,2323,480,2324],"class_list":["post-19330","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-atencio-primaria","tag-comparacions-indirectes","tag-farmacia-clinica","tag-farmacia-hospitalaria","tag-metanalisi-en-xarxa"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Taller de comparacions indirectes i metan\u00e0lisi en xarxa - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Taller de comparacions indirectes i metan\u00e0lisi en xarxa - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"\u201cCada any es comercialitzen nous principis actius i nous medicaments per indicacions on ja tenim diferents tractaments establerts. Les ag\u00e8ncies reguladores, tant a nivell americ\u00e0 com a nivell europeu, nom\u00e9s requereixen a la ind\u00fastria farmac\u00e8utica que el nou medicament hagi demostrat efic\u00e0cia i seguretat enfront placebo per donar l\u2019autoritzaci\u00f3 a [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-02-23T12:31:28+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Taller de comparacions indirectes i metan\u00e0lisi en xarxa\",\"datePublished\":\"2016-02-23T12:31:28+00:00\",\"dateModified\":\"2016-02-23T12:31:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/\"},\"wordCount\":655,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Atenci\u00f3 prim\u00e0ria\",\"comparacions indirectes\",\"farm\u00e0cia cl\u00ednica\",\"farm\u00e0cia hospital\u00e0ria\",\"metan\u00e0lisi en xarxa\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/\",\"name\":\"Taller de comparacions indirectes i metan\u00e0lisi en xarxa - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2016-02-23T12:31:28+00:00\",\"dateModified\":\"2016-02-23T12:31:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Taller de comparacions indirectes i metan\u00e0lisi en xarxa\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Taller de comparacions indirectes i metan\u00e0lisi en xarxa - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/","og_locale":"ca_ES","og_type":"article","og_title":"Taller de comparacions indirectes i metan\u00e0lisi en xarxa - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"\u201cCada any es comercialitzen nous principis actius i nous medicaments per indicacions on ja tenim diferents tractaments establerts. Les ag\u00e8ncies reguladores, tant a nivell americ\u00e0 com a nivell europeu, nom\u00e9s requereixen a la ind\u00fastria farmac\u00e8utica que el nou medicament hagi demostrat efic\u00e0cia i seguretat enfront placebo per donar l\u2019autoritzaci\u00f3 a [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2016-02-23T12:31:28+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"3 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Taller de comparacions indirectes i metan\u00e0lisi en xarxa","datePublished":"2016-02-23T12:31:28+00:00","dateModified":"2016-02-23T12:31:28+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/"},"wordCount":655,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#primaryimage"},"thumbnailUrl":"","keywords":["Atenci\u00f3 prim\u00e0ria","comparacions indirectes","farm\u00e0cia cl\u00ednica","farm\u00e0cia hospital\u00e0ria","metan\u00e0lisi en xarxa"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/","url":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/","name":"Taller de comparacions indirectes i metan\u00e0lisi en xarxa - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#primaryimage"},"thumbnailUrl":"","datePublished":"2016-02-23T12:31:28+00:00","dateModified":"2016-02-23T12:31:28+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2016\/02\/23\/taller-de-comparacions-indirectes-i-metaanalisi-en-xarxa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Taller de comparacions indirectes i metan\u00e0lisi en xarxa"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"\u201cCada any es comercialitzen nous principis actius i nous medicaments per indicacions on ja tenim diferents tractaments establerts. Les ag\u00e8ncies reguladores, tant a nivell americ\u00e0 com a nivell europeu, nom\u00e9s requereixen a la ind\u00fastria farmac\u00e8utica que el nou medicament hagi demostrat efic\u00e0cia i seguretat enfront placebo per donar l\u2019autoritzaci\u00f3 a [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/19330","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=19330"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/19330\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=19330"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=19330"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=19330"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}